Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABEO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABEO Options Chain |
| Stock Message Boards |
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on August 08, 2022, ABEO opened at $4.25, traded as high as $4.39 and as low as $3.97, and closed at $4.02. Trading volume was a total of 349.00K shares. On August 09, 2022, ABEO opened at $4.00, traded as high as $4.03 and as low as $3.88, and closed at $3.95. Trading volume was a total of 163.70K shares. On August 10, 2022, ABEO opened at $4.10, traded as high as $4.21 and as low as $3.90, and closed at $4.16. Trading volume was a total of 267.00K shares. On August 11, 2022, ABEO opened at $3.97, traded as high as $5.29 and as low as $3.97, and closed at $4.66. Trading volume was a total of 1.48M shares. On August 12, 2022, ABEO opened at $4.62, traded as high as $4.99 and as low as $4.38, and closed at $4.43. Trading volume was a total of 339.80K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 08/14/2012 | |
| End date: | 08/12/2022 | |
| Start price/share: | $12.25 | |
| End price/share: | $4.43 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -63.84% | |
| Average Annual Total Return: | -9.67% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $3,616.76 | |
| Years: | 10.00 | |
 | |||||
| ABEO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 08/08/2022 | $4.25 | $4.39 | $3.97 | $4.02 | 349.00K |
| 08/09/2022 | $4.00 | $4.03 | $3.88 | $3.95 | 163.70K |
| 08/10/2022 | $4.10 | $4.21 | $3.90 | $4.16 | 267.00K |
| 08/11/2022 | $3.97 | $5.29 | $3.97 | $4.66 | 1.48M |
| 08/12/2022 | $4.62 | $4.99 | $4.38 | $4.43 | 339.80K |
|
| About Abeona Therapeutics |
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. |
| ABEO Historical Closing Prices | |
| Date | Close |
| 08/08/2022 | $4.02 |
| 08/09/2022 | $3.95 |
| 08/10/2022 | $4.16 |
| 08/11/2022 | $4.66 |
| 08/12/2022 | $4.43 |
| Healthcare Historical Prices |
| ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABIO Historical Stock Prices Also explore: ABEO shares outstanding history
|
Free ABEO Email Alerts:
